BioTuesdays Feature Articles | Life Sciences News

Feature

NuPulseCV evaluating new intravascular ventricular assist system

By Len Zehr Closely-held NuPulseCV is enrolling patients with advanced heart failure in a feasibility study with its intravascular ventricular assist system (iVAS), a minimally invasive heart pump designed to allow...

April 2, 2019

Feature

Vessi Medical developing new treatment for superficial bladder cancer

By Len Zehr Closely-held Vessi Medical wants to change the standard of care for superficial bladder cancer by using a surface cryotherapy approach in a minimally invasive in-office treatment alternative to surgery. “We...

March 26, 2019

Feature

Corindus banking on telerobotics potential to treat stroke

By Len Zehr After recently conducting five first-in-man coronary stent procedures robotically in India, Corindus Vascular Robotics (NASDAQ:CVRS) plans to perform its first remote vascular cases in the U.S. in mid-2019...

March 19, 2019

Feature

DxTerity bringing at-home precision medicine to patients with autoimmune diseases

By Len Zehr Closely-held DxTerity has developed the first affordable diagnostics platform for at-home monitoring of autoimmune disease activity and response to drug treatment, with tests that use longitudinal gene...

March 12, 2019

Feature

In Conversation with Gregory Montalbano of MIDI

By Len Zehr As a principal of closely-held MIDI Medical Product Development, Greg Montalbano has a unique background in industrial design, usability/ergonomics and manufacturing with over 25 years of experience...

March 5, 2019

Feature

PharmaJet injection devices creating needle-free world

By Len Zehr Closely-held PharmaJet’s needle-free injection devices have the potential to rapidly improve the delivery of vaccines in emerging markets as well as pharmaceuticals currently under development. “We are at...

February 26, 2019

Feature

Lineagen champions clinical information solutions for autism spectrum disorders and other neurodevelopmental conditions

By Len Zehr Closely-held Lineagen has developed and commercialized a comprehensive portfolio of behavioral screening and genetic tests for autism spectrum disorders (ASD) and other forms of childhood neurodevelopmental...

February 19, 2019

Feature

ImpediMed sees revenue upswing from new SaaS business model

ImpediMed’s (ASX:IPD) transition to a software-as-a-service (SaaS) subscription business model in 2018, in conjunction with the introduction of the SOZO Digital Health Platform, is already paying off on the top line.

February 12, 2019

Feature

Interface Biologics to focus future growth in biotech with local drug delivery platform

Closely-held Interface Biologics, best known for improving the safety and efficacy of medical devices through its Endexo surface modification technology, is pegging its future growth on biotech, with an initial focus on...

February 5, 2019

Feature

Karius diagnostic test enabling precision medicine for infectious diseases

Closely-held Karius has developed and commercialized a next-generation sequencing test that can identify and quantify microbial cell-free DNA from more than 1,300 bacteria, viruses, fungi and parasites using a non...

January 29, 2019

Feature

Novavax to report key vaccine data in first quarter

Novavax (NASDAQ:NVAX) is scheduled to report pivotal data in the current quarter for ResVax, its RSV (respiratory syncytial virus) F vaccine, using aluminum phosphate as an adjuvant, in infants via maternal immunization.

January 22, 2019

Feature

Titan Pharma relaunch of Probuphine paying early dividends

Titan Pharmaceuticals’ (NASDAQ:TTNP) relaunch of its Probuphine implant for the long-term maintenance treatment of opioid use disorder (OUD) demonstrated promising results with a meaningful increase in product shipments...

January 15, 2019

Feature

BeyondSpring readies NDA filings for Plinabulin in U.S. and China

BeyondSpring (NASDAQ:BYSI) is preparing to file NDAs with the China FDA during the next six months for its lead asset, first-in-class agent Plinabulin, for the treatment of non-small cell lung cancer (NSCLC) and...

January 8, 2019

Feature

Canopy Health to expand clinical mandate with Constellation Brands investment

Canopy Health Innovations, the research subsidiary of Canopy Growth (TSX:WEED; NYSE:CGC) that focuses on the development of therapeutic and natural health cannabis products, will get a big boost from a blockbuster $5...

December 11, 2018

Feature

Zuga Medical readying U.S. rollout of ZugaLink cloud platform to support digital dentistry

Closely-held Zuga Medical expects to roll out its digital dental implant solution, known as ZugaLink, across the U.S. in 2019. “Digital dentistry is the future of dentistry, with computer-aided design (CAD), computer...

December 4, 2018

Feature

Penta Medical commercializing wearable cold laser therapy device for chronic and acute injuries

Closely-held Penta Medical is now on the sales and marketing trail, targeting sports teams, orthopedic doctors and physical therapists with its PentaVO device. The wearable cold laser therapy and data collection device...

November 27, 2018

Feature

TRACON Pharma gears for important near-term milestones

TRACON Pharmaceuticals (NASDAQ:TCON) is expected to report several important potential milestones over the next two quarters, including two randomized data points from its product development pipeline.

November 20, 2018

Feature

Robert Foster swinging for the fence again with ContraVir Pharma

Dr. Robert Foster is teeing up another possible home run as the new CEO of ContraVir Pharmaceuticals (NASDAQ:CTRV) and its lead programs for liver disease arising from chronic viral infection and NASH (non-alcoholic...

November 13, 2018

Feature

Trendlines cites hands-on approach to growth of its investment portfolio

With 11 years of progressive growth in the value of its expanding portfolio, The Trendlines Group (SGX:42T; OTCQX:TRNLY), an Israeli investment company, takes a very hands-on approach with its early-stage medical and...

November 6, 2018

Feature

In conversation with Dr. Femida Gwadry-Sridhar of Pulse Infoframe

As founder and CEO of closely-held Pulse Infoframe, a leading cloud-based healthcare data insights company, Dr. Femida Gwadry-Sridhar’s resume boasts a deep background as a pharmacist, epidemiologist and methodologist...

October 30, 2018

Feature

MagnetTx developing combined MRI and linac for cancer radiation therapy

By Len Zehr Closely-held MagnetTx Oncology Solutions filed a 510(k) application with the FDA in September for its Aurora RT device, which combines the accuracy of magnetic resonance imaging (MRI) with linear accelerator...

October 23, 2018

Feature

Rgenix’s discovery platform identifying novel RNA-regulated cancer targets

By Len Zehr Closely-held Rgenix has identified novel cancer targets regulated by microRNA pathways, which are key drivers of cancer progression, and developed first-in-class treatments that have the potential to...

October 16, 2018

Subscribe